Table 1.
Subset | Common γ‐δ chain pairings | Anatomical localisation | Context for the production of IFN‐γ or IL‐17 | Other effector molecules |
---|---|---|---|---|
Mousea | ||||
Vγ1 | Vγ1Vδ6.3/6.4 | Liver, secondary lymphoid organs | IFN‐γ – cancer,25 viral infection26 | TNF, IL‐427 |
Vγ2 | Undefined | Liver, lung (rare) | Undefined | Undefined |
Vγ4 | Vγ4Vδ4 | Lung, liver, dermis, lamina propria, secondary lymphoid organs | IFN‐γ – cancer,28 IL‐17 – skin injury29 | TNF, IL‐2230 |
Vγ5 | Vγ5Vδ1 (DETC) | Epidermis | IFN‐γ – cancer, TLR signalling,31 NKG2D ligation31 | TNF, IL‐2232 |
Vγ6 | Vγ6Vδ1 | Uterine epithelia, lung | IL‐17 – bacterial infection,33 cancer34 | IL‐2235 |
Vγ7 | Vγ7Vδ4/5/6 | Gut epithelia | IFN‐γ – bacterial infection27 | IL‐4, IL‐1027 |
Human | ||||
Vδ1 | Undefined | Gut epithelia, liver, dermis | IFN‐γ – cancer,36 IL‐17 – colorectal cancer37 | TNF,36 IL‐1023 |
Vδ2 | Vγ9Vδ2 | Peripheral blood | IFN‐γ – cancer, phosphoantigen stimulation8IL‐17 – bacterial infection24 | TNF,21 IL‐9,22 IL‐1023 |
Vδ3 | Undefined | Gut epithelia, liver | IFN‐γ – glycolipids38 | TNF, IL‐438 |
Heilig and Tonegawa nomenclature.